Do cannabinoids exhibit a tyramine-like effect?

Author： Ilayan Eman   Feliszek Monika   Malinowska Barbara   Schlicker Eberhard  

Publisher： Springer Publishing Company

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.386, Iss.12, 2013-12, pp. : 1041-1046

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of the tyramine fragment of opioid receptor ligands on their agonist and antagonist properties

By Kuz’mina N.   Osipova E.   Kuz’min V.   Sitnikov V.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 5, 2006-05 ,pp. : 254-260

Springer Publishing Company

Access to resources Recommend Favorite

Cannabinoids

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 507-530

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Applications of Selective and Non-Selective Inhibitors of Monoamine Oxidase A and B that do not Cause Significant Tyramine Potentiation

By Youdim M.B.H.   Weinstock M.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 243-250

Elsevier

Access to resources Recommend Favorite

Cannabinoids in Multiple Sclerosis: Do They Have a Therapeutic Role?

By Killestein J.   Uitdehaag B.M.J.   Polman C.H.  

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite